AbbVie Inc. (ABBV)

NYSE: ABBV · Real-Time Price · USD

193.41

-1.69 (-0.87%)

At close: May 01, 2025, 3:59 PM

193.10

-0.16%

After-hours: May 01, 2025, 07:57 PM EDT

AbbVie Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	56.33B	54.32B	58.05B	56.2B	45.8B	33.27B	32.75B	28.22B	25.64B
Cost of Revenue	16.9B	20.41B	17.41B	17.45B	15.39B	7.44B	7.72B	7.04B	5.83B
Gross Profit	39.43B	33.9B	40.64B	38.75B	30.42B	25.83B	25.04B	21.18B	19.8B
Operating Income	9.14B	12.76B	18.12B	17.92B	11.36B	12.98B	6.38B	9.54B	9.34B
Interest Income	648M	540M	186M	39M	174M	275M	204M	146M	82M
Pretax Income	3.72B	6.25B	13.48B	12.99B	3.4B	8.43B	5.2B	7.73B	7.88B
Net Income	4.28B	4.86B	11.84B	11.54B	4.62B	7.88B	5.69B	5.31B	5.95B
Selling & General & Admin	14.75B	12.87B	15.26B	12.35B	11.3B	6.94B	7.4B	6.28B	5.86B
Research & Development	12.79B	8.45B	6.51B	7.08B	6.56B	6.41B	10.33B	4.98B	4.37B
Other Expenses	2.75B	n/a	56M	432M	-5.61B	-890M	-18M	-513M	-232M
Operating Expenses	30.29B	21.15B	21.83B	19.86B	17.86B	12.46B	18.23B	11.26B	10.22B
Interest Expense	2.81B	2.22B	2.23B	2.42B	2.45B	1.78B	1.35B	1.15B	1.05B
Selling & Marketing Expenses	n/a	2.2B	2B	2.1B	1.8B	1.1B	1.1B	846M	764M
Cost & Expenses	47.2B	41.56B	39.94B	38.27B	34.44B	20.28B	26.37B	18.67B	16.3B
Income Tax Expense	-570M	1.38B	1.63B	1.44B	1.22B	544M	490M	2.42B	1.93B
Shares Outstanding (Basic)	1.77B	1.77B	1.77B	1.77B	1.67B	1.48B	1.54B	1.6B	1.62B
Shares Outstanding (Diluted)	1.77B	1.77B	1.78B	1.78B	1.67B	1.48B	1.55B	1.6B	1.63B
EPS (Basic)	2.42	2.73	6.65	6.48	2.73	5.30	3.69	3.31	3.65
EPS (Diluted)	2.39	2.72	6.63	6.45	2.72	5.28	3.68	3.30	3.63
EBITDA	14.91B	17.31B	31.42B	28.28B	21.15B	16.26B	13.69B	11.77B	10.81B
EBIT	6.52B	8.61B	15.71B	15.41B	5.85B	10.21B	11.92B	10.27B	8.93B
Depreciation & Amortization	8.39B	8.7B	8.47B	8.52B	6.47B	2.02B	1.76B	1.5B	1.19B